4′-Fluorouridine works against RNA-dependent RNA polymerase, an enzyme that helps viruses assemble RNA. The compound has a ...

Theratechnologies gains exclusive rights to two investigational RNA-targeted medicines from Ionis Pharmaceuticals, olezarsen ...

Get the last 2 weeks biotech industry news in this quick roundup of the last fortnight's products, people and partnerships ...

A study from researchers at the University of Michigan and the University of California San Diego has shed light on a ...

Dominique Verhelle is co-founder and CEO of the Brighton-based company NextRNA Therapeutics, which uses long non-coding RNA ...

The heart has long been thought to be controlled solely by the autonomic nervous system, which transmits signals from the ...

For decades, scientists believed the heart was a normal organ controlled entirely by the brain. Now, the picture just got a ...

Choosing a film for a movie night is always a battle. Now imagine if you could pick one that provided a window into some of ...

The Alliance for Pharmacy Compounding rebutted Novo's FDA petition to bar compounding pharmacies from copying its weight loss ...

"RNA sequencing (RNA-seq) is a powerful technique that allows scientists to analyze the quantity and variety of RNA in a sample. This helps researchers understand gene expression and how it affects ...

Theratechnologies (THTX) has entered into an agreement with Ionis Pharmaceuticals to license two investigational RNA-targeted ...